These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31303359)

  • 1. State targeted response to the opioid Crisis grants (opioid STR) program: Preliminary findings from two case studies and the national cross-site evaluation.
    High PM; Marks K; Robbins V; Winograd R; Manocchio T; Clarke T; Wood C; Stringer M
    J Subst Abuse Treat; 2020 Jan; 108():48-54. PubMed ID: 31303359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation and evaluation of Missouri's Medication First treatment approach for opioid use disorder in publicly-funded substance use treatment programs.
    Winograd RP; Wood CA; Stringfellow EJ; Presnall N; Duello A; Horn P; Rudder T
    J Subst Abuse Treat; 2020 Jan; 108():55-64. PubMed ID: 31277891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders.
    Reif S; Brolin MF; Stewart MT; Fuchs TJ; Speaker E; Mazel SB
    J Subst Abuse Treat; 2020 Jan; 108():33-39. PubMed ID: 31358328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to the special issue on innovative interventions and approaches to expand medication assisted treatment: Seizing research opportunities made available by the opioid STR program.
    Watson DP; Andraka-Christou B; Clarke T; Wiegandt J
    J Subst Abuse Treat; 2020 Jan; 108():1-3. PubMed ID: 31668689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The case for a medication first approach to the treatment of opioid use disorder.
    Winograd RP; Presnall N; Stringfellow E; Wood C; Horn P; Duello A; Green L; Rudder T
    Am J Drug Alcohol Abuse; 2019; 45(4):333-340. PubMed ID: 31084515
    [No Abstract]   [Full Text] [Related]  

  • 6. Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural southern state.
    Bogan C; Jennings L; Haynes L; Barth K; Moreland A; Oros M; Goldsby S; Lane S; Funcell C; Brady K
    J Subst Abuse Treat; 2020 Mar; 112S():73-78. PubMed ID: 32220414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).
    D'Onofrio G; Edelman EJ; Hawk KF; Pantalon MV; Chawarski MC; Owens PH; Martel SH; VanVeldhuisen P; Oden N; Murphy SM; Huntley K; O'Connor PG; Fiellin DA
    Implement Sci; 2019 May; 14(1):48. PubMed ID: 31064390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder.
    Abraham AJ; Andrews CM; Grogan CM; Pollack HA; D'Aunno T; Humphreys K; Friedmann PD
    Psychiatr Serv; 2018 Apr; 69(4):448-455. PubMed ID: 29241428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting.
    Cisewski DH; Santos C; Koyfman A; Long B
    Am J Emerg Med; 2019 Jan; 37(1):143-150. PubMed ID: 30355476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoting sustainable responses to the US opioid epidemic with community-academic partnerships: qualitative outcomes from a statewide program.
    Driscoll DL; Cuellar AE; Agarwal V; Jones D; Dunkenberger MB; Hosig K
    Subst Abuse Treat Prev Policy; 2022 Apr; 17(1):26. PubMed ID: 35392939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania.
    Kawasaki S; Francis E; Mills S; Buchberger G; Hogentogler R; Kraschnewski J
    J Subst Abuse Treat; 2019 Nov; 106():58-64. PubMed ID: 31540612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of an emergency department-based recovery coaching intervention and pilot testing of pragmatic trial protocols within the context of Indiana's Opioid State Targeted Response plan.
    Watson DP; Brucker K; McGuire A; Snow-Hill NL; Xu H; Cohen A; Campbell M; Robison L; Sightes E; Buhner R; O'Donnell D; Kline JA
    J Subst Abuse Treat; 2020 Jan; 108():88-94. PubMed ID: 31200985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organizational factors associated with practitioners' support for treatment of opioid use disorder in the emergency department.
    Guerrero E; Ober AJ; Howard DL; Khachikian T; Kong Y; van Deen WK; Valdez A; Trotzky-Sirr R; Menchine M
    Addict Behav; 2020 Mar; 102():106197. PubMed ID: 31862684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond Buprenorphine: Models of Follow-up Care for Opioid Use Disorder in the Emergeny Department.
    Martin A; Butler K; Chavez T; Herring A; Wakeman S; Hayes BD; Raja A
    West J Emerg Med; 2020 Nov; 21(6):257-263. PubMed ID: 33207174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deploying science to change hearts and minds: Responding to the opioid crisis.
    Walsh SL; Long KQX
    Prev Med; 2019 Nov; 128():105780. PubMed ID: 31319116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responding to the opioid and overdose crisis with innovative services: The recovery community center office-based opioid treatment (RCC-OBOT) model.
    Ashford RD; Brown AM; McDaniel J; Neasbitt J; Sobora C; Riley R; Weinstein L; Laxton A; Kunzelman J; Kampman K; Curtis B
    Addict Behav; 2019 Nov; 98():106031. PubMed ID: 31326776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the needs of front-line providers in addressing the opioid crisis in South Carolina.
    Moreland A; McCauley J; Barth K; Bogdon C; Killeen T; Haynes L; Jennings L; Guille C; Goldsby S; Brady K
    J Subst Abuse Treat; 2020 Jan; 108():4-8. PubMed ID: 31303360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of the hub and spoke model for opioid use disorders in California: Rationale, design and anticipated impact.
    Miele GM; Caton L; Freese TE; McGovern M; Darfler K; Antonini VP; Perez M; Rawson R
    J Subst Abuse Treat; 2020 Jan; 108():20-25. PubMed ID: 31399272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The payer's role in addressing the opioid epidemic: It's more than money.
    Molfenter T; McCarty D; Jacobson N; Kim JS; Starr S; Zehner M
    J Subst Abuse Treat; 2019 Jun; 101():72-78. PubMed ID: 31174716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 21
    Beletsky L
    Am J Law Med; 2018 May; 44(2-3):359-385. PubMed ID: 30106650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.